In the first reported case of the autoinflammatory VEXAS syndrome in South Africa, J Damelin, J Jacobson, C Bam, L Pillay and ...
Women who accidentally fall pregnant while taking a GLP-1 treatment for diabetes or weight loss are not at increased risk of ...
This week on Why Did I Become A Doctor?, in partnership with MedicalBrief, Dr Suhayl Essa talks medicine, comedy, burnout, ...
A breast cancer diagnosis and the illnesses that followed transformed Kwanele Asante into one of Africa’s most prominent ...
Some patients’ accounts raise tantalising questions about what happens inside a brain afflicted by dementia and whether ...
Under a new health accountability framework endorsed by the 81st UN General Assembly (UNGA) last month in New York, African governments have committed to subjecting their progress on maternal and ...
In efforts to sustain the use of GLP-1 drugs by its members – most of whom stop claiming for the treatment within six months – Discovery’s rewards scheme Vitality is stepping up its support, saying ...
It isn’t always easy to know what to believe when it comes to cancer. In the Daily Maverick and Spotlight special series on cancer, Biénne Huisman asks whether cases are on the increase in South ...
Merck has announced that it will no longer manufacture or market the antibacterial combination drug Recarbrio as “part of an ongoing review of its portfolio and unrelated to any product safety or ...
If R182m meant for an already buckling health system can be poured into PR with so few checks, imagine the risks when the NHI becomes the country’s single, centralised purchaser of healthcare, writes ...
Women with peripheral artery disease are less likely than men to receive a timely diagnosis or recommended care, which can further jeopardise cardiovascular health, warn experts in The Washington Post ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results